4//SEC Filing
Tesi Raymond Joseph 4
Accession 0001213900-21-055422
CIK 0001711754other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 4:03 PM ET
Size
4.7 KB
Accession
0001213900-21-055422
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
- Sale
Common Stock
2021-10-27$20.00/sh−6,517$130,340→ 1,494,300 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767280
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 4:03 PM ET
- Size
- 4.7 KB